04-28-2021, 12:12 AM
The European database of suspected drug reaction reports is EudraVigilance, which also tracks reports of injuries and deaths following the experimental COVID-19 “vaccines.”
Here is what EudraVigilance states about their database:
This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.
EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.
This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.
The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.
Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source.)
Their report through April 17, 2021 lists 7,766 deaths and 330,218 injuries following injections of four experimental COVID-19 shots:
COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Here is the summary data through April 17, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 4,293 deaths and 144,607 injuries to 17/04/2021
10,754 Blood and lymphatic system disorders incl. 37 deaths
6,993 Cardiac disorders incl. 499 deaths
45 Congenital, familial and genetic disorders incl. 2 deaths
3,944 Ear and labyrinth disorders incl. 3 deaths
103 Endocrine disorders
4,388 Eye disorders incl. 5 deaths
32,024 Gastrointestinal disorders incl. 216 deaths
99,747 General disorders and administration site conditions incl. 1397 deaths
199 Hepatobiliary disorders incl. 15 deaths
3,165 Immune system disorders incl. 19 deaths
9,534 Infections and infestations incl. 512 deaths
3,653 Injury, poisoning and procedural complications incl. 79 deaths
7,166 Investigations incl. 161 deaths
2,407 Metabolism and nutrition disorders incl. 85 deaths
51,699 Musculoskeletal and connective tissue disorders incl. 44 deaths
133 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
63,051 Nervous system disorders incl. 393 deaths
177 Pregnancy, puerperium and perinatal conditions incl. 7 deaths
76 Product issues
5,684 Psychiatric disorders incl. 60 deaths
885 Renal and urinary disorders incl. 62 deaths
911 Reproductive system and breast disorders incl. 1 death
13,181 Respiratory, thoracic and mediastinal disorders incl. 490 deaths
15,325 Skin and subcutaneous tissue disorders incl. 35 deaths
409 Social circumstances incl. 6 deaths
111 Surgical and medical procedures incl. 6 deaths
7,694 Vascular disorders incl. 152 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 2,094 deaths and 15,979 injuries to 17/04/2021
766 Blood and lymphatic system disorders incl. 14 deaths
1,184 Cardiac disorders incl. 206 deaths
8 Congenital, familial and genetic disorders incl. 2 deaths
339 Ear and labyrinth disorders
20 Endocrine disorders
518 Eye disorders incl. 3 deaths
3,523 Gastrointestinal disorders incl. 75 deaths
11,366 General disorders and administration site conditions incl. 938 deaths
69 Hepatobiliary disorders incl. 3 deaths
439 Immune system disorders incl. 1 death
1,299 Infections and infestations incl. 107 deaths
707 Injury, poisoning and procedural complications incl. 41 deaths
5356 Investigations incl. 58 deaths
472 Metabolism and nutrition disorders incl. 42 deaths
5,163 Musculoskeletal and connective tissue disorders incl. 44 deaths
46 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
6,834 Nervous system disorders incl. 215 deaths
44 Pregnancy, puerperium and perinatal conditions
8 Product issues
782 Psychiatric disorders incl. 31 deaths
271 Renal and urinary disorders incl. 20 deaths
96 Reproductive system and breast disorders incl. 1 death
2,019 Respiratory, thoracic and mediastinal disorders incl. 181 deaths
1,947 Skin and subcutaneous tissue disorders incl. 19 deaths
151 Social circumstances incl. 6 deaths
100 Surgical and medical procedures incl. 12 deaths
1,035 Vascular disorders incl. 68 deaths
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 1,360 deaths and 169,386 injuries to 17/04/2021
4,740 Blood and lymphatic system disorders incl. 61 deaths
6,744 Cardiac disorders incl. 172 deaths
67 Congenital, familial and genetic disorders incl. 2 death
4,480 Ear and labyrinth disorders
127 Endocrine disorders incl. 2 deaths
6,983 Eye disorders incl. 5 deaths
52,560 Gastrointestinal disorders incl. 54 deaths
130,827General disorders and administration site conditions incl. 442 deaths
203 Hepatobiliary disorders incl. 6 deaths
1,666 Immune system disorders incl. 6 deaths
9,789 Infections and infestations incl. 88 deaths
3,736 Injury, poisoning and procedural complications incl. 16 deaths
8,792 Investigations incl. 19 deaths
6,575 Metabolism and nutrition disorders incl. 14 deaths
76,467 Musculoskeletal and connective tissue disorders incl. 13 deaths
125 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
103,240Nervous system disorders incl. 207 deaths
88 Pregnancy, puerperium and perinatal conditions
42 Product issues
8,740 Psychiatric disorders incl. 10 deaths
1,609 Renal and urinary disorders incl. 10 deaths
1,688 Reproductive system and breast disorders
14,224 Respiratory, thoracic and mediastinal disorders incl. 130 deaths
21,280 Skin and subcutaneous tissue disorders incl. 9 deaths
330 Social circumstances incl. 3 deaths
351 Surgical and medical procedures incl. 10 deaths
7,427 Vascular disorders incl. 78 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 19 deaths and 246 injuries to 17/04/2021
(No graph yet)
9 Blood and lymphatic system disorders incl. 1 death
29 Cardiac disorders incl. 5 deaths
1 Congenital, familial and genetic disorder
16 Ear and labyrinth disorders
1 Endocrine disorder
14 Eye disorders
61 Gastrointestinal disorders
154 General disorders and administration site conditions incl. 8 deaths
4 Hepatobiliary disorders
10 Immune system disorders
27 Infections and infestations
16 Injury, poisoning and procedural complications
40 Investigations
12 Metabolism and nutrition disorders
59 Musculoskeletal and connective tissue disorders
0 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
138 Nervous system disorders incl. 1 death
0 Pregnancy, puerperium and perinatal conditions
1 Product issue
24 Psychiatric disorders
9 Renal and urinary disorders incl. 1 death
4 Reproductive system and breast disorders
49 Respiratory, thoracic and mediastinal disorders incl. 1 death
28 Skin and subcutaneous tissue disorders
4 Social circumstances
4 Surgical and medical procedures
44 Vascular disorders incl. 2 deaths
This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.
Denmark and Norway have completely suspended use of the AstraZeneca experimental COVID-19 shots.
A statement issued by the Norwegian Institute of Public Health stated that the AstraZeneca COVID “vaccine” is more dangerous than COVID itself, especially for young people.
The EMA continues to recommend it. They did, however, add a safety warning to the J&J shots, due to fatal blood clots.
https://vaccineimpact.com/2021/7766-dead...-vaccines/
Here is what EudraVigilance states about their database:
This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.
EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.
This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.
The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.
Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source.)
Their report through April 17, 2021 lists 7,766 deaths and 330,218 injuries following injections of four experimental COVID-19 shots:
COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Here is the summary data through April 17, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 4,293 deaths and 144,607 injuries to 17/04/2021
10,754 Blood and lymphatic system disorders incl. 37 deaths
6,993 Cardiac disorders incl. 499 deaths
45 Congenital, familial and genetic disorders incl. 2 deaths
3,944 Ear and labyrinth disorders incl. 3 deaths
103 Endocrine disorders
4,388 Eye disorders incl. 5 deaths
32,024 Gastrointestinal disorders incl. 216 deaths
99,747 General disorders and administration site conditions incl. 1397 deaths
199 Hepatobiliary disorders incl. 15 deaths
3,165 Immune system disorders incl. 19 deaths
9,534 Infections and infestations incl. 512 deaths
3,653 Injury, poisoning and procedural complications incl. 79 deaths
7,166 Investigations incl. 161 deaths
2,407 Metabolism and nutrition disorders incl. 85 deaths
51,699 Musculoskeletal and connective tissue disorders incl. 44 deaths
133 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
63,051 Nervous system disorders incl. 393 deaths
177 Pregnancy, puerperium and perinatal conditions incl. 7 deaths
76 Product issues
5,684 Psychiatric disorders incl. 60 deaths
885 Renal and urinary disorders incl. 62 deaths
911 Reproductive system and breast disorders incl. 1 death
13,181 Respiratory, thoracic and mediastinal disorders incl. 490 deaths
15,325 Skin and subcutaneous tissue disorders incl. 35 deaths
409 Social circumstances incl. 6 deaths
111 Surgical and medical procedures incl. 6 deaths
7,694 Vascular disorders incl. 152 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 2,094 deaths and 15,979 injuries to 17/04/2021
766 Blood and lymphatic system disorders incl. 14 deaths
1,184 Cardiac disorders incl. 206 deaths
8 Congenital, familial and genetic disorders incl. 2 deaths
339 Ear and labyrinth disorders
20 Endocrine disorders
518 Eye disorders incl. 3 deaths
3,523 Gastrointestinal disorders incl. 75 deaths
11,366 General disorders and administration site conditions incl. 938 deaths
69 Hepatobiliary disorders incl. 3 deaths
439 Immune system disorders incl. 1 death
1,299 Infections and infestations incl. 107 deaths
707 Injury, poisoning and procedural complications incl. 41 deaths
5356 Investigations incl. 58 deaths
472 Metabolism and nutrition disorders incl. 42 deaths
5,163 Musculoskeletal and connective tissue disorders incl. 44 deaths
46 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
6,834 Nervous system disorders incl. 215 deaths
44 Pregnancy, puerperium and perinatal conditions
8 Product issues
782 Psychiatric disorders incl. 31 deaths
271 Renal and urinary disorders incl. 20 deaths
96 Reproductive system and breast disorders incl. 1 death
2,019 Respiratory, thoracic and mediastinal disorders incl. 181 deaths
1,947 Skin and subcutaneous tissue disorders incl. 19 deaths
151 Social circumstances incl. 6 deaths
100 Surgical and medical procedures incl. 12 deaths
1,035 Vascular disorders incl. 68 deaths
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 1,360 deaths and 169,386 injuries to 17/04/2021
4,740 Blood and lymphatic system disorders incl. 61 deaths
6,744 Cardiac disorders incl. 172 deaths
67 Congenital, familial and genetic disorders incl. 2 death
4,480 Ear and labyrinth disorders
127 Endocrine disorders incl. 2 deaths
6,983 Eye disorders incl. 5 deaths
52,560 Gastrointestinal disorders incl. 54 deaths
130,827General disorders and administration site conditions incl. 442 deaths
203 Hepatobiliary disorders incl. 6 deaths
1,666 Immune system disorders incl. 6 deaths
9,789 Infections and infestations incl. 88 deaths
3,736 Injury, poisoning and procedural complications incl. 16 deaths
8,792 Investigations incl. 19 deaths
6,575 Metabolism and nutrition disorders incl. 14 deaths
76,467 Musculoskeletal and connective tissue disorders incl. 13 deaths
125 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
103,240Nervous system disorders incl. 207 deaths
88 Pregnancy, puerperium and perinatal conditions
42 Product issues
8,740 Psychiatric disorders incl. 10 deaths
1,609 Renal and urinary disorders incl. 10 deaths
1,688 Reproductive system and breast disorders
14,224 Respiratory, thoracic and mediastinal disorders incl. 130 deaths
21,280 Skin and subcutaneous tissue disorders incl. 9 deaths
330 Social circumstances incl. 3 deaths
351 Surgical and medical procedures incl. 10 deaths
7,427 Vascular disorders incl. 78 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 19 deaths and 246 injuries to 17/04/2021
(No graph yet)
9 Blood and lymphatic system disorders incl. 1 death
29 Cardiac disorders incl. 5 deaths
1 Congenital, familial and genetic disorder
16 Ear and labyrinth disorders
1 Endocrine disorder
14 Eye disorders
61 Gastrointestinal disorders
154 General disorders and administration site conditions incl. 8 deaths
4 Hepatobiliary disorders
10 Immune system disorders
27 Infections and infestations
16 Injury, poisoning and procedural complications
40 Investigations
12 Metabolism and nutrition disorders
59 Musculoskeletal and connective tissue disorders
0 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
138 Nervous system disorders incl. 1 death
0 Pregnancy, puerperium and perinatal conditions
1 Product issue
24 Psychiatric disorders
9 Renal and urinary disorders incl. 1 death
4 Reproductive system and breast disorders
49 Respiratory, thoracic and mediastinal disorders incl. 1 death
28 Skin and subcutaneous tissue disorders
4 Social circumstances
4 Surgical and medical procedures
44 Vascular disorders incl. 2 deaths
This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.
Denmark and Norway have completely suspended use of the AstraZeneca experimental COVID-19 shots.
A statement issued by the Norwegian Institute of Public Health stated that the AstraZeneca COVID “vaccine” is more dangerous than COVID itself, especially for young people.
The EMA continues to recommend it. They did, however, add a safety warning to the J&J shots, due to fatal blood clots.
https://vaccineimpact.com/2021/7766-dead...-vaccines/